Taspine derivative TAS9 regulates cell growth and metastasis of human hepatocellular carcinoma

Liu,Rui; Wang,Wenjie; Dai,Bingling; Liu,Yanping; Zhang,Yanmin

doi:10.3892/mmr.2015.4398

Taspine derivative TAS9 regulates cell growth and metastasis of human hepatocellular carcinoma

Authors:
- Rui Liu
- Wenjie Wang
- Bingling Dai
- Yanping Liu
- Yanmin Zhang
View Affiliations

Affiliations: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: September 30, 2015 https://doi.org/10.3892/mmr.2015.4398
Pages: 7735-7741

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Taspine has been indicated to be a potential anti‑carcinogenic agent. The present study investigated the effects of TAS9, a modified taspine derivative, on the proliferation and migration of the SMMC‑7721 human liver cancer cell line. First, the effects of TAS9 on SMMC‑7721 cell growth were examined using MTT and colony formation assaya. In vivo Transwell and wound healing assays were then performed to assess the inhibitory effects of TAS9 on cell invasion and migration, respectively. The expression of cell proliferation‑ and migration‑associated signaling molecules was investigated by western blot analysis. The results indicated that TAS9 inhibited SMMC‑7721 cell growth by downregulating the signaling molecules protein kinase Cβ (PKCβ), Akt, mammalian target of rapamycin, mitogen‑activated protein kinase kinase 2, RAF and c‑Jun N‑terminal kinase‑1, and inhibiting SMMC‑7721 cell migration by suppressing the expression of matrix metalloproteinase (MMP)‑2, MMP‑9, chemokine (C‑X‑C motif) receptor 4, nuclear factor κB, p38 and p53. Small interfering RNA‑mediated knockdown of PKCβ in the SMMC‑7721 cells significantly attenuated the tumor inhibitory effects of TAS9. In conclusion, the results of the present study suggested that TAS9 may have inhibitory effects on the proliferation and migration of SMMC‑7721 cells, and may serve as a potential candidate for cancer treatment.

View Figures

View References

1	Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, Li G, Nie Y, Lo CM, Teoh N, et al: PPARgamma inhibits hepatocellular carcinoma metastases in-vivo and in mice. Br J Cancer. 106:1486–1494. 2012. View Article : Google Scholar : PubMed/NCBI
2	Yodkeeree S, Chaiwangyen W, Garbisa S and Limtrakul P: Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem. 20:87–95. 2009. View Article : Google Scholar
3	Zhen C, Chen L, Zhao Q, Liang B, Gu YX, Bai ZF, Wang K, Xu X, Han QY, Fang DF, et al: Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene. 32:3452–3460. 2013. View Article : Google Scholar
4	Kim GD, Oh J, Park HJ, Bae K and Lee SK: Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells. Int J Oncol. 43:600–610. 2013.PubMed/NCBI
5	Song MK, Kim YJ, Song M, Choi HS, Park YK and Ryu JC: Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction. Cancer Sci. 102:1636–1644. 2011. View Article : Google Scholar : PubMed/NCBI
6	Hidalgo M and Eckhardt SG: Development of matrix metal-loproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 93:178–193. 2001. View Article : Google Scholar : PubMed/NCBI
7	Zhang XX, Fu ZY, Zhang Z, Miao C, Xu P, et al: Microcystin-LR promotes melanoma cell invasion and enhances matrix metal-loproteinase-2/-9 expression mediated by NFκB activation. Environ Sci Technol. 46:11319–11326. 2012. View Article : Google Scholar : PubMed/NCBI
8	Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
9	Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, et al: Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model. BMC Cancer. 12:1662012. View Article : Google Scholar : PubMed/NCBI
10	Perdue G, Blomster RN, Blake DA and Farnsworth NR: South-American plants II: Taspine isolation and anti-inflammatory activity. J Pharm Sci. 68:124–126. 1979. View Article : Google Scholar : PubMed/NCBI
11	Rollinger JM, Schuster D, Baier E, Ellmerer EP, Langer T and Stuppner H: Taspine: Bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana. J Nat Prod. 69:1341–1346. 2006. View Article : Google Scholar : PubMed/NCBI
12	Porras-Reyes BH, Lewis WH, Roman J, Simchowitz L and Mustoe TA: Enhancement of wound healing by the alkaloid taspine defining mechanism of action. Proc Soc Exp Biol Med. 203:18–25. 1993. View Article : Google Scholar : PubMed/NCBI
13	Itokawa H, Ichihara Y, Mochizuki M, Enomori T, Morita H, Shirota O, Inamatsu M and Takeya K: A cytotoxic substance from Sangre De Grado. Chem Pharm Bull. 39:1041–1042. 1991. View Article : Google Scholar : PubMed/NCBI
14	Zhang YM, He LC, Meng L, Luo WJ and Xu XM: Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vivo. Cancer Lett. 262:103–113. 2008. View Article : Google Scholar : PubMed/NCBI
15	Zhang YM, Jiang Q, Wang N, Dai B, Chen Y and He L: Effects of taspine on proliferation and apoptosis by regulating caspase-3 expression and the ratio of Bax/Bcl-2 in A431 Cells. Phytother Res. 25:357–364. 2011.
16	Gao HP, Su P, Shi YL, Shen X, Zhang Y, Dong J and Zhang J: Discovery of novel VEGFR-2 inhibitors. Part II: Biphenyl urea incorporated with salicylaldoxime. Eur J Med Chem. 90:232–240. 2015. View Article : Google Scholar
17	Zinda MJ, Johnson MA, Paul JD, Horn C, Konicek BW, Lu ZH, Sandusky G, Thomas JE, Neubauer BL, Lai MT, et al: AKT-1,-2, and-3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res. 7:2475–2479. 2001.PubMed/NCBI
18	Hay N: The Akt-mTOR tango and its relevance to cancer. Cancer Cell. 8:179–183. 2005. View Article : Google Scholar : PubMed/NCBI
19	Faivre S, Kroemer G and Raymond E: Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov. 5:671–688. 2006. View Article : Google Scholar : PubMed/NCBI
20	Philippi A, Roschmann E, Tores F, Lindenbaum P, Benajou A, Germain-Leclerc L, Marcaillou C, Fontaine K, Vanpeene M, Roy S, et al: Haplotypes in the gene encoding protein kinase c-beta (PRKCB1) on chromosome 16 are associated with autism. Mol Psychiatr. 10:950–960. 2005. View Article : Google Scholar
21	Lintas C, Sacco R, Garbett K, Mirnics K, Militerni R, Bravaccio C, Curatolo P, Manzi B, Schneider C, Melmed R, et al: Involvement of the PRKCB1 gene in autistic disorder: Significant genetic association and reduced neocortical gene expression. Mol Psychiatry. 14:705–718. 2009. View Article : Google Scholar
22	Chuang SM, Wang IC and Yang JL: Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Carcinogenesis. 21:1423–1432. 2000. View Article : Google Scholar : PubMed/NCBI
23	Luo W, Wang X, Zheng L, Zhan Y, Zhang D, Zhang J and Zhang Y: Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway. J Cell Mol Med. 17:1316–1324. 2013. View Article : Google Scholar : PubMed/NCBI
24	Balan V, Leicht DT, Zhu J, Balan K, Kaplun A, Singh-Gupta V, Qin J, Ruan H, Comb MJ and Tzivion G: Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase. Mol Biol Cell. 17:1141–1153. 2006. View Article : Google Scholar : PubMed/NCBI
25	Lou L, Ye W, Chen Y, Wu S, Jin L, He J, Tao X, Zhu J, Chen X, Deng A, et al: Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine. 19:603–608. 2012. View Article : Google Scholar : PubMed/NCBI
26	Adams LS, Phung S, Yee N, Seeram NP, Li L and Chen S: Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res. 70:3594–3605. 2010. View Article : Google Scholar : PubMed/NCBI
27	Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ and Lv GY: Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem. 25:177–185. 2014. View Article : Google Scholar : PubMed/NCBI
28	Chen Y, Stamatoyannopoulos G and Song CZ: Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vivo. Cancer Res. 63:4801–4804. 2003.PubMed/NCBI
29	Shen HM and Tergaonkar V: NF kappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis. 14:348–363. 2009. View Article : Google Scholar : PubMed/NCBI
30	Wang Z, Banerjee S, Li Y, Rahman KMW, Zhang Y and Sarkar FH: Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res. 66:2778–2784. 2006. View Article : Google Scholar : PubMed/NCBI
31	O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW: Role of the p53 tumor-suppressor gene in cell-cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53:4776–4780. 1993.PubMed/NCBI
32	Sharma GD, He J and Bazan HE: p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: Evidence of cross-talk activation between MAP kinase cascades. J Biol Chem. 278:21989–21997. 2003. View Article : Google Scholar : PubMed/NCBI
33	Surdez D, Benetkiewicz M, Perrin V, Han ZY, Pierron G, Ballet S, Lamoureux F, Rédini F, Decouvelaere AV, Daudigeos-Dubus E, et al: Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKCβ abolishes ewing sarcoma growth. Cancer Res. 72:4494–4503. 2012. View Article : Google Scholar : PubMed/NCBI